Clinical Operations Specialist
ICON plc
Summary
At ICON Strategic Solutions, you will work in a sponsor-dedicated model, supported by ICON's global expertise. As a Study Start Up Associate II at ICON, you will lead the initiation of clinical trials, ensuring compliance with regulatory requirements, and contribute to the advancement of innovative treatments and therapies.
Job description
What You Will Do
You will contribute to site start-up and activation activities, taking responsibility for your deliverables and working collaboratively.
Key responsibilities include
- Coordinate country and site start up activities against study timelines.
- Collect, review and track essential regulatory and site documents.
- Support ethics, regulatory and site submission activities as applicable.
- Identify start up risks and follow actions through resolution.
- Maintain accurate status and documentation in relevant clinical systems.
Working conditions
- Willingness to travel as required (approximately 5%).
Requirements
- Bachelor's degree in life sciences or a related field.
- Minimum of 2 years of experience in clinical research or regulatory affairs, with specific experience in study start up activities.
- Understanding of regulatory requirements and guidelines for clinical trials, including ICH Good Clinical Practice (GCP) and local regulatory requirements.
- Relevant life sciences, healthcare, regulatory or clinical research experience.
- Knowledge of ICH Good Clinical Practice (GCP) and clinical study start up processes.
- Experience coordinating site activation, regulatory submissions or essential documents.
- Experience coordinating country and site start up activities against study timelines.
- Willingness to travel as required (approximately 5%).
Benefits
- Competitive base salary
- Performance incentives
- Medical, Dental & Vision
- Retirement & pension plans
- Life assurance
- Disability coverage
- Employee assistance programme
- Wellbeing resources
- Learning & development
Company overview
ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.